ArticleInternational medical case reports journal2026
Apical Hypertrophic Cardiomyopathy Misdiagnosed as Hypertensive Heart Disease Due to Anchoring Bias in an African Man: A Case Report.
Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Apical hypertrophic cardiomyopathy (ApHCM) is an uncommon variant of hypertrophic cardiomyopathy, accounting for approximately 5-10% of all cases. It is frequently misdiagnosed as hypertensive heart disease in African patients with longstanding hypertension, particularly in resource-limited settings where cardiac magnetic resonance imaging (CMR) is unavailable. Anchoring bias, the tendency to adhere to an initial diagnosis despite contradictory evidence is a well-recognized contributor to this diagnostic error. Case Presentation: A 60-year-old African man with a 15-year history of hypertension presented with exertional dyspnea and palpitations. Initial differentials included hypertensive heart disease, coronary artery disease, and dilated cardiomyopathy. Troponin I was negative. Electrocardiography revealed deep symmetric T-wave inversions (7-9 mm) in anterolateral leads without voltage criteria for left ventricular hypertrophy. Transthoracic echocardiography demonstrated apical-predominant hypertrophy (apical wall 18 mm, posterior wall 11 mm; ratio 1.6), preserved ejection fraction (55-60%), and classic systolic apical cavity obliteration with an ace-of-spades configuration. Speckle-tracking echocardiography showed selective apical longitudinal strain reduction (-12%) with preserved basal strain (-18%). These findings established ApHCM. Dual renin-angiotensin system blockade and unindicated clopidogrel were discontinued, bisoprolol was optimized, and symptoms resolved completely within two weeks. Conclusion: Deep T-wave inversions without voltage criteria for left ventricular hypertrophy should prompt focused apical echocardiographic assessment, even in patients with longstanding hypertension. An apical-to-posterior wall thickness ratio of at least 1.5 with systolic apical cavity obliteration permits ApHCM diagnosis without CMR. Selective apical strain reduction distinguishes ApHCM from hypertensive heart disease. Recognizing anchoring bias is essential to avoid diagnostic delay when electrocardiographic and echocardiographic findings are discordant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.